Cme (CME) Depreciation & Amortization (CF) (2010 - 2026)

Cme (CME) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $28.2 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) rose 3.3% year-over-year to $28.2 million; the TTM figure through Jun 2026 stood at $81.8 million (down 1.21% YoY), while the FY2025 annual figure was $107.5 million, down 6.6% from the prior year.
• Depreciation & Amortization (CF) advanced to $28.2 million in Q2 2026 per CME's latest filing, from $27.2 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $34.5 million in Q3 2022 and bottomed at $26.4 million in Q3 2025.
• Historically, Depreciation & Amortization (CF) has averaged $30.0 million across 5 years, with a median of $29.4 million in 2024.
• Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) declined 11.15% — and 2026, when it grew 3.3%.
• Cme's Depreciation & Amortization (CF) stood at $34.5 million in 2022, then decreased by 9.86% to $31.1 million in 2023, then declined by 9.32% to $28.2 million in 2024, then declined by 6.38% to $26.4 million in 2025, then grew by 6.82% to $28.2 million in 2026.
• Business Quant data shows CME's Depreciation & Amortization (CF) at $28.2 million in Q2 2026, $27.2 million in Q1 2026, and $26.4 million in Q3 2025.